This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

Skip to main content
CanJMedSpec
  • Menu
  • Articles
    • General Interest
    • Pathology
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Advertising
  • Join CJMS / Contact Us
  • search
  • X (formerly Twitter) (opens in a new tab)
  • Bluesky (opens in a new tab)
  • RSS feed (opens a modal with a link to feed)

RSS Feed

Enter the URL below into your favorite RSS reader.

http://localhost:13535/feed
ISSN 2819-2842
Pathology
Vol. 2, Issue 1, 2026February 18, 2026 ADT

Metastatic PEComa successfully treated with pembrolizumab: A case report and review of the literature

John Loggie, M.D., M.Sc., Mathieu Castonguay, M.D., Kelly Dakin Haché, M.D., Ph.D., Bruce Colwell, M.D., Michael Carter, M.D., Ph.D.,
immunotherapymicrosatellite instabilityPerivascular Epithelioid Cell NeoplasmsbiomarkersDNA mismatch repairpathology
Copyright Logoccby-nc-nd-4.0 • https://doi.org/10.63838/001c.154978
Photo by Indra Projects on Unsplash
CanJMedSpec
1.
Loggie J, Castonguay M, Dakin Haché K, Colwell B, Carter M. Metastatic PEComa successfully treated with pembrolizumab: A case report and review of the literature. CanJMedSpec. 2026;2(1):18-23. doi:10.63838/​001c.154978

View more stats

Powered by Scholastica, the modern academic journal management system